Clinical Trial

The CROCO Study: CROhn's Disease COhort Study

Study acronym: CROCO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The goal of the CROCO Study - "Crohn's Disease Cohort Study" is to promote a greater understanding of the long-term evolution of Crohn Disease , to describe prospectively the impact of different therapeutic strategies and develop accurate predictors of bowel disease damage and disability.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-07-29
notable Enrollment reduced: 600 -> 533 participants 2026-07-29
Trial Details
NCT Number NCT05420233
Lead Sponsor GLSMED Learning Health S.A.
Collaborators: AbbVie
Conditions Crohn Disease
Enrollment 533 participants
Start Date 2021-08-01
Primary Completion 2030-07 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-28